Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024 Revenue generated by Breathe Life Sciences (BLS) slipped to A$1.7 million in Q3 FY24 with parent […]
Melodiol flags possible sale of core assets to raise capital by Steve Jones December 11, 2023December 13, 2023
Company news: Setek Therapeutics; Emyria; Melodiol Global Health by Martin Lane October 9, 2023April 30, 2024
Company news: Helius; Dragonfly; Medlab; MGC Pharma; Entoura; Creso; Southern Cannabis Holdings by Martin Lane January 12, 2023April 29, 2024
